Current value sales of topical antifungals witnessed positive growth in 2022 following two years of decline. Topical antifungals was hit hard by the COVID-19 pandemic as fewer opportunities to visit gyms and swimming pools limited sports activities. Also, with more time at home, consumers had more time devote to personal hygiene and take better preventative action against getting fungal infections. In 2022, the category is now seeing a recovery as people return to normal activities and engage in...
Euromonitor International's Dermatologicals in Ecuador report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Dermatologicals in Ecuador
Euromonitor International
September 2022
List Of Contents And Tables
DERMATOLOGICALS IN ECUADOR
KEY DATA FINDINGS
2022 DEVELOPMENTS
Topical antifungals begin to recover after pandemic causes decline
Medicated shampoo is a growth area
Nappy (Rash) treatments recovering as consumer purchasing power improves
PROSPECTS AND OPPORTUNITIES
Dermatologicals to make further strong recovery as people go back to normal life
Return to classes will boost the sales of Antiparasitics/Lice (Head and Body) Treatments
New players will grow hair loss treatments
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2017-2022
Table 2 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 4 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 5 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN ECUADOR
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources